757
report
Employer Investments in Digital, Whole-Person Health for Substance Use Disorders
Employers seek to support their employees while normalizing a whole-person approach to substance us
e disorders (SUD). The response to addiction and the opioid crisis requires a whole-of-society approach, including employers of all sizes.
+ Read More
report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
+ Read More
panel
Common Sense from Uncommon Investors
With the emergence of rapidly rising interest rates and the resultant global recession fears, no
w is the time to remind investors about the cyclical nature of financial markets. Should managers batten down the hatches?
+ Read More
panel
Print is Not Dead
panel
Open Private Session (Invite only)
panel
Russia, Ukraine and its Neighborhood: Preparing to Win the Peace (Invite only)
While states make war, war totally remakes states. The Ukraine and Russia that finish the war wi
ll be radically changed from those before hostilities started.
+ Read More
panel
Open Private Session (Invite only)
panel
How Do Drugs Get Approved Faster Using RWE and AI?
Real-world evidence (RWE) and artificial intelligence (AI) have the potential to accelerate drug
development via multiple mechanisms, providing valuable insights into drug safety and efficacy in the real-world setting.
+ Read More
panel
The Path to Board Diversity: Moving the Needle from Progress to Maintenance (Invite only)
Board compositions are under increasing scrutiny worldwide when it comes to diverse representati
on.
+ Read More